Sutro Biopharma (STRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

We recently compiled a list of the 10 Most Promising Energy Stocks According to Hedge Funds. In this article, we are going to take a look at where NextEra Energy, Inc. (NYSE:NEE) stands against the ...

This week marks a big moment for tech investors as perhaps the most anticipated earnings of the year will be released: Nvidia ...

Microsoft (MSFT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead ...

Super Micro Computer (NASDAQ: SMCI) stock has been in free fall for the last six months. A myriad of issues related to its ...

Tesla is offering three months of free Supercharging and FSD to customers taking deliveries of a new vehicle by the end of ...

The Glendale, California-based company is joining a host of high-profile startups looking to go public as strengthening bets of a soft-landing for the U.S. economy improve investor sentiment. Sweden's ...

Astera Labs receives a 'Buy' rating with a $110 target price, driven by strong growth in connectivity solutions and ...

Exchange-traded funds that buy Chinese stocks continue to see outflows amid rising concerns over the nation’s growth outlook ...

Walmart, Target, Aldi and other grocers are competing for a place on holiday tables with turkey dinner deals and other ...

IRIS.TV uses an artificial intelligence-enhanced proprietary video content identifier that provides contextual and brand-suitability data to advertisers.

Steve Young, managing partner at Manna Tree, explains what is driving the fierce M&A activity in the food industry right now ...